May Measurement Month 2023: Implementation of a global opportunistic blood pressure screening campaign in Greece
Clicks: 1
ID: 319059
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
0.0
/100
1 views
0 readers
AI Quality Assessment
Not analyzed
Readership in this journal
Ranked #246 of 282 articles by views in European heart journal supplements : journal of the European Society of Cardiology
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 282 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Abstract The May Measurement Month (MMM) 2023 global blood pressure (BP) screening campaign was conducted in Greece aiming to raise hypertension awareness and control in the general population. Volunteers aged ≥18 years were recruited through opportunistic screening in 11 cities. Each participant was assessed with triplicate seated BP measurements using validated automated upper-arm cuff devices and a standardized questionnaire on medical history. These data were submitted online through a custom-designed app of the global MMM campaign. Hypertension was defined as BP ≥140/90mmHg (average of second-third measurement) and/or use of antihypertensive drugs. A total of 5,437 individuals were analysed (mean age 53±17.1 years, 46.2% men, 27.8% current smokers, 10.9% with diabetes, 6.7% with cardiovascular disease) and 41.7% were hypertensive. The prevalence of hypertension was higher in men compared to women and in older compared to youngers individuals. Among hypertensives, 73.9% were unaware of their diagnosis, 69.9% were on antihypertensive drugs, and 47.6% were treated and controlled (BP <140/90mmHg). These data suggest that in Greece a high prevalence of hypertension persists, and often is undiagnosed, untreated, and uncontrolled. Global BP screening campaigns such as MMM are important and need to be complemented by public health initiatives at a national level for improving hypertension diagnosis and control.
| Reference Key |
openalex_W7166562942
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Ariadni Menti, Αναστάσιος Κόλλιας, Haralampos Milionis, Angelos Liontos, Εugenia Gkaliagkousi, Vasilios Kotsis, C S Savopoulos, Αreti Triantafyllou, Ιoannis Zarifis, Spyridon Maragkoudakis, Xenophon Krokidis, Maria Marketou, Vasilios Sarakis, George Ntaios, Emmanouil Makaris, George Nikitas, Dimitrios Goumenos, Evangelos Papachristou, Charalampos Grassos, Rigas Kalaitzidis, Manolis S. Kallistratos, Vasiliki Katsi, D. Konstantinidis, Konstantinos G. Kyriakoulis, Thomas Makris, Efstathios Manios, ATHANASIOS MANOLIS, Dimitrios Papadopoulos, Maria Pikilidou, Athanase D. Protogerou, Pantelis Sarafidis, Marieta Theodorakopoulou, Costas Thomopoulos, Pantelis Zebekakis, Konstantinos Tsioufis, Michael Doumas, Thomas Beaney, Gabriele Kerr, Neil R Poulter, George S. Stergiou |
| Journal | European heart journal supplements : journal of the European Society of Cardiology |
| Year | 2026 |
| DOI |
10.1093/eurheartjsupp/suag095
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.